389 related articles for article (PubMed ID: 10780321)
1. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity.
Lackner KJ; von Landenberg C; Barlage S; Schmitz G
Thromb Haemost; 2000 Apr; 83(4):583-8. PubMed ID: 10780321
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease.
von Landenberg C; Lackner KJ; von Landenberg P; Lang B; Schmitz G
J Autoimmun; 1999 Sep; 13(2):215-23. PubMed ID: 10479390
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of antiphospholipid syndrome-IgG fractions and human monoclonal antiphospholipid IgG antibody on human umbilical vein endothelial cells and monocytes.
Clemens N; Frauenknecht K; Katzav A; Sommer C; von Landenberg P
Ann N Y Acad Sci; 2009 Sep; 1173():805-13. PubMed ID: 19758232
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of low doses of tumor necrosis factor and sera from patients with systemic lupus erythematosus on the expression of procoagulant activity by cultured endothelial cells.
Hasselaar P; Derksen RH; Oosting JD; Blokzijl L; de Groot PG
Thromb Haemost; 1989 Sep; 62(2):654-60. PubMed ID: 2510346
[TBL] [Abstract][Full Text] [Related]
5. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
6. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
[TBL] [Abstract][Full Text] [Related]
7. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
9. Protean clinical presentation of antiphospholipid-protein antibodies (APA).
Triplett DA
Thromb Haemost; 1995 Jul; 74(1):329-37. PubMed ID: 8578480
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of a human IgG monoclonal antiphospholipid antibody.
Prinz N; Häuser F; Lorenz M; Lackner KJ; von Landenberg P
Immunobiology; 2011; 216(1-2):145-51. PubMed ID: 20591533
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of anticardiolipin antibodies from patients with the antiphospholipid syndrome and with syphilis on platelet activation and aggregation.
Campbell AL; Pierangeli SS; Wellhausen S; Harris EN
Thromb Haemost; 1995 Mar; 73(3):529-34. PubMed ID: 7667838
[TBL] [Abstract][Full Text] [Related]
12. Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis.
Harrison CN; Donohoe S; Carr P; Dave M; Mackie I; Machin SJ
Thromb Haemost; 2002 May; 87(5):802-7. PubMed ID: 12038780
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
Ames PR; Pyke S; Iannaccone L; Brancaccio V
Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
[TBL] [Abstract][Full Text] [Related]
14. Increased monocyte procoagulant activity independent of the lupus anticoagulant in patients with systemic lupus erythematosus.
de Prost D; Ollivier V; Ternisien C; Chollet-Martin S
Thromb Haemost; 1990 Oct; 64(2):216-21. PubMed ID: 2125372
[TBL] [Abstract][Full Text] [Related]
15. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.
Reverter JC; Tàssies D; Font J; Khamashta MA; Ichikawa K; Cervera R; Escolar G; Hughes GR; Ingelmo M; Ordinas A
Arthritis Rheum; 1998 Aug; 41(8):1420-7. PubMed ID: 9704640
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
17. Antibody and immune complexes induce tissue factor production by human endothelial cells.
Tannenbaum SH; Finko R; Cines DB
J Immunol; 1986 Sep; 137(5):1532-7. PubMed ID: 3745915
[TBL] [Abstract][Full Text] [Related]
18. Detection of acquired resistance to activated protein C associated with antiphospholipid antibodies using a novel clotting assay.
Gardiner C; Cohen H; Jenkins A; Machin SJ; Mackie IJ
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):477-83. PubMed ID: 16905952
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies bind to activated but not resting endothelial cells: is an independent triggering event required to induce antiphospholipid antibody-mediated disease?
Chen Q; Stone PR; Woon ST; Ching LM; Hung S; McCowan LM; Chamley LW
Thromb Res; 2004; 114(2):101-11. PubMed ID: 15306152
[TBL] [Abstract][Full Text] [Related]
20. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies.
Kornberg A; Blank M; Kaufman S; Shoenfeld Y
J Immunol; 1994 Aug; 153(3):1328-32. PubMed ID: 8027560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
